| National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, National Dental Practice-Based Research Network |
RFA-DE-20-005 |
UG3, UH3 |
|
| NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed)
|
|
Career Development, Training & Fellowships |
RFA-NS-20-015 |
R25 |
|
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
Related Notice
|
|
Behavioral & Social Science, Bioinformatics, Computational Biology & Data Science, Clinical Research & Clinical Trials, Common Fund Programs, Conferences & Meetings, Craniofacial & Dental Development, Disorders, Craniofacial Skeletal Biology & Pathobiology, Dental Caries, Dental Materials & Biomaterials, Dissemination and Implementation Science, Epidemiology, Fluoride & Fluorosis, Gene Discovery, Genomics and Multi-Omics Analysis, Global Health, Health Disparities, HIV/AIDS and Oral Health, International Research Activities, Mineralized Tissues & Mineralization |
RFA-DE-20-002 |
R35 |
|
| Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
RFA-NS-18-046 |
R33, R61 |
|
| Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-NS-18-041 |
R33, R61 |
|
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
|
|
Common Fund Programs |
RFA-RM-19-012 |
R03 |
|
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
Related Notice
|
|
Parent Announcements & Trans-NIH Announcements, Small Business (SBIR/STTR) |
PA-19-270 |
R41, R42 |
|
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Related Notice
|
|
Parent Announcements & Trans-NIH Announcements, Small Business (SBIR/STTR) |
PA-19-272 |
R43, R44 |
|
| Administrative Supplements for Research on Dietary Supplements (Admin Supp)
|
|
Parent Announcements & Trans-NIH Announcements |
PA-18-817 |
P30, P40, P50 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
|
|
Bioinformatics, Computational Biology & Data Science, Oral, Oropharyngeal & Salivary Gland Cancers |
PA-17-239 |
R01 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
|
|
Bioinformatics, Computational Biology & Data Science, Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-243 |
R21 |
|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
PAR-18-541 |
U44 |
|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
PAR-18-546 |
UG3, UH3 |
|
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
|
|
Behavioral & Social Science, Health Disparities |
PAR-17-464 |
R21 |
|
| Research to Improve Native American Health (R21 Clinical Trials Optional)
|
|
Clinical Research & Clinical Trials, Health Disparities |
PAR-17-464 |
R21 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-475 |
R21 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-476 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional)
|
|
Behavioral & Social Science |
PAR-18-611 |
R21 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional)
|
|
Behavioral & Social Science |
PAR-18-612 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-845 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
|
|
Health Disparities, Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-846 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-848 |
R21 |
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, HIV/AIDS and Oral Health |
PAR-18-190 |
R21 |
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, HIV/AIDS and Oral Health |
PAR-18-189 |
R01 |
|
| Emerging Global Leader Award (K43 Independent Clinical Trial Required)
|
|
Career Development, Training & Fellowships |
PAR-19-038 |
K43 |
|
